TCDA News and Press, Tricida Inc. From 03/01/22

SOUTH SAN FRANCISCO, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to slow chronic...

Toragen (NASDAQ:TCDA) announces that Dr. Sandra Coufal, M.D. will join Toragen as its new CEO.  Dr. Coufal brings over 30 years of experience as a physician and serial entrepreneur working with multiple successful companies in medicine, chemistry, biotechnology, material s...

Tricida Inc. (NASDAQ:TCDA) traded at a new 52-week high today of $10.55. So far today approximately 131,000 shares have been exchanged, as compared to an average 30-day volume of 363,000 shares. Over the past year, Tricida Inc. has traded in a range of $3.55 to $10.55 and is now at $9.72...

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 7:30 am PT / 10:30 am ET. Gerrit Klaerner, Ph.D., Tricida’s Foun...

Shares of Tricida Inc. (NASDAQ:TCDA) traded today at $9.79, eclipsing its 52-week high. Approximately 131,000 shares have changed hands today, as compared to an average 30-day volume of 361,000 shares. Tricida Inc. (NASDAQ:TCDA) has potential upside of 40.5% based on a current price of $...

Tricida Inc. (NASDAQ:TCDA) traded today at a new 52-week high of $9.53. Approximately 131,000 shares have changed hands today, as compared to an average 30-day volume of 468,000 shares. Tricida Inc. has overhead space with shares priced $9.53, or 30.7% below the average consensus analyst...

Tricida Inc. (NASDAQ:TCDA) traded today at a new 52-week high of $9.21. This new high was reached on below average trading volume as 131,000 shares traded hands, while the average 30-day volume is approximately 471,000 shares. Tricida Inc. share prices have moved between a 52-week high o...

Tricida Inc. (NASDAQ:TCDA) traded at a new 52-week high today of $8.70. This new high was reached on below average trading volume as 131,000 shares traded hands, while the average 30-day volume is approximately 417,000 shares. Tricida Inc is a pharmaceutical company focused on the develo...

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 10:30 am PT / 1:30 pm ET. Gerrit Klaerner, Ph.D., Tricida’s Foun...

Gainers: Stitch Fix  (NASDAQ:SFIX) +2%. Fate Therapeutics (NASDAQ:FATE) +2%. Frequency Therapeutics (NASDAQ:FREQ) +1%. Criteo  (NASDAQ:CRTO) +1%. EVgo  (NASDAQ:EVGO) +1%. Losers: Nexters  (NASDAQ:GDEV) -3%. Ocular Therapeutix (NASDAQ:OCUL) -2%. Sig...